Inställningar

Split view

Short keys for navigating in split view

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Dark Mode

Set dark mode to MFN.se

Sound

Plays a notification sound when new press release is published in the current feed

07:10:02 Europe / Stockholm

Svenska | English

BioStock

Alligator Bioscience: BioStock: Orion option exercise triggers milestone payment for Alligator

2024-05-02 08:57:27

The collaboration between Alligator Bioscience and the global pharma company Orion Corporation continues to bear fruit. Orion has chosen to exercise its option to develop new antibody cancer therapeutics leveraging Alligator's antibody discovery technologies and RUBY bispecific format.
- With this option exercise, we believe Orion has selected considerably differentiated bispecific antibodies that could lead to highly innovative treatments, says Alligator's CEO Søren Bregenholt.

Read the article at biostock.se:

Orion option exercise triggers milestone payment for Alligator - BioStock (https://www.biostock.se/en/2024/05/orion-option-exercise-triggers-milestone-payment-for-alligator/)
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

BioStock

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden